Article info

Download PDFPDF
Can transcutaneous bilirubinometry safely be used to monitor rebound hyperbilirubinaemia after phototherapy in neonates ≥35 weeks’ gestation? A prospective, comparative study

Authors

  1. Correspondence to Dr Helen Mactier, Neonatal Unit, Princess Royal Maternity Hospital, Glasgow G31 2ER, UK; Helen.Mactier{at}glasgow.ac.uk
View Full Text

Citation

Butterworth FR, Boulton R, Campbell S, et al
Can transcutaneous bilirubinometry safely be used to monitor rebound hyperbilirubinaemia after phototherapy in neonates ≥35 weeks’ gestation? A prospective, comparative study

Publication history

  • Received July 28, 2023
  • Accepted March 15, 2024
  • First published April 10, 2024.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.